Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
This pilot phase II trial studies how well giving vaccine therapy works in treating patients
with stage IIC-IV melanoma. Vaccines made from melanoma peptides or antigens may help the
body build an effective immune response to kill tumor cells